Novocure Ltd (NVCR)
Novocure Ltd (NVCR) is a NASDAQ-listed healthcare equipment and supplies company, and the security context here is common equity. The listing represents ordinary shares in Novocure Ltd rather than a fund, debt instrument, or other special security. Based on its business classification, the company is associated with device-based cancer care and related medical technology activities. The shares trade on NASDAQ under the symbol NVCR and should be understood as an equity interest in the issuer. This overview describes the security type and market listing, not a recommendation or a forecast about its prospects.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-NVCR
|
$18.36
|
13.5% Upside
|
Fair
|
$24.88
|
53.8% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
July 23, 2026
|
-10.9x
|
5.7x
|
2.8x
|
1.846 B
|
1.686 B
|
11.3%
|
82.2%
|
0.3
|
—
|
27.8%
|
